Vincent Guerlavais

1.9k total citations
22 papers, 650 citations indexed

About

Vincent Guerlavais is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vincent Guerlavais has authored 22 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vincent Guerlavais's work include Cancer-related Molecular Pathways (8 papers), Advanced Breast Cancer Therapies (5 papers) and Muscle Physiology and Disorders (4 papers). Vincent Guerlavais is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), Advanced Breast Cancer Therapies (5 papers) and Muscle Physiology and Disorders (4 papers). Vincent Guerlavais collaborates with scholars based in United States, France and Italy. Vincent Guerlavais's co-authors include Manuel Aivado, D. Allen Annis, Jean Martínez, Luis A. Carvajal, Jean‐Alain Fehrentz, Funda Meric‐Bernstam, Patrick J. Carroll, Vojislav Vukovic, Ulrich Steidl and Madeleine M. Joullié and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Vincent Guerlavais

20 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vincent Guerlavais United States 11 397 214 102 76 66 22 650
Daniel J. Burdick United States 13 353 0.9× 77 0.4× 96 0.9× 26 0.3× 47 0.7× 19 613
Dennis G. Fry United States 12 210 0.5× 104 0.5× 39 0.4× 52 0.7× 18 0.3× 19 377
Joseph L. Meuth United States 13 407 1.0× 45 0.2× 109 1.1× 199 2.6× 167 2.5× 18 947
Jenny Chik Australia 5 490 1.2× 78 0.4× 108 1.1× 12 0.2× 142 2.2× 7 621
Naoki Teno Japan 15 218 0.5× 156 0.7× 133 1.3× 44 0.6× 13 0.2× 52 561
Shihong Ma United States 16 334 0.8× 193 0.9× 23 0.2× 27 0.4× 49 0.7× 26 713
Wenjing Shang China 14 556 1.4× 112 0.5× 55 0.5× 18 0.2× 48 0.7× 30 802
Johnathan C. Maher United States 10 552 1.4× 190 0.9× 19 0.2× 9 0.1× 120 1.8× 18 892
Agata Steenackers France 15 506 1.3× 69 0.3× 187 1.8× 16 0.2× 219 3.3× 22 631
Susan M. Medghalchi United States 13 1.0k 2.6× 105 0.5× 76 0.7× 27 0.4× 42 0.6× 17 1.3k

Countries citing papers authored by Vincent Guerlavais

Since Specialization
Citations

This map shows the geographic impact of Vincent Guerlavais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Guerlavais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Guerlavais more than expected).

Fields of papers citing papers by Vincent Guerlavais

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Guerlavais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Guerlavais. The network helps show where Vincent Guerlavais may publish in the future.

Co-authorship network of co-authors of Vincent Guerlavais

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Guerlavais. A scholar is included among the top collaborators of Vincent Guerlavais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Guerlavais. Vincent Guerlavais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Xuyu, et al.. (2025). Using muscle homing peptide CyPep10 to deliver phosphorodiamidate morpholino oligomers in the mdx mouse. Molecular Therapy — Nucleic Acids. 36(3). 102625–102625.
2.
Guerlavais, Vincent, Tomi K. Sawyer, Luis A. Carvajal, et al.. (2023). Discovery of Sulanemadlin (ALRN-6924), the First Cell-Permeating, Stabilized α-Helical Peptide in Clinical Development. Journal of Medicinal Chemistry. 66(14). 9401–9417. 79 indexed citations
3.
Saleh, Mansoor N., Manish R. Patel, Todd M. Bauer, et al.. (2021). Phase 1 Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53. Clinical Cancer Research. 27(19). 5236–5247. 110 indexed citations
4.
Zhou, Xiaolei, Madhurendra Singh, Gema Sanz, et al.. (2021). Pharmacologic Activation of p53 Triggers Viral Mimicry Response Thereby Abolishing Tumor Immune Evasion and Promoting Antitumor Immunity. Cancer Discovery. 11(12). 3090–3105. 113 indexed citations
5.
Zhao, Ming, Erkan Yuca, Kurt W. Evans, et al.. (2021). First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models. Breast Cancer Research. 23(1). 29–29. 48 indexed citations
6.
7.
Carvajal, Luis A., David Sutton, Joseph McClanaghan, et al.. (2019). Abstract C064: The investigational peptide drug ALRN-6924, a dual inhibitor of MDMX and MDM2, is an effective myelopreservation agent. Molecular Cancer Therapeutics. 18(12_Supplement). C064–C064. 2 indexed citations
8.
Shustov, Andrei R., Amitkumar Mehta, Lubomir Sokol, et al.. (2018). Pseudoprogression (PsP) in Patients with Peripheral T-Cell Lymphoma (PTCL) Treated with the Novel Stapled Peptide ALRN-6924, a Dual Inhibitor of MDMX and MDM2. Blood. 132(Supplement 1). 5348–5348. 4 indexed citations
9.
Meric‐Bernstam, Funda, Mansoor N. Saleh, Jeffrey R. Infante, et al.. (2017). Phase I trial of a novel stapled peptide ALRN-6924 disrupting MDMX- and MDM2-mediated inhibition of WT p53 in patients with solid tumors and lymphomas.. Journal of Clinical Oncology. 35(15_suppl). 2505–2505. 62 indexed citations
10.
Chang, Yong S., Bradford Graves, Vincent Guerlavais, et al.. (2012). 226 ATSP-7041, a Dual MDM2 and MDMX Targeting Stapled A-helical Peptide Exhibits Potent in Vitro and in Vivo Efficacy in Xenograft Models of Human Cancer. European Journal of Cancer. 48. 68–69. 3 indexed citations
11.
Nehmé, Reine, Catherine Perrin, Vincent Guerlavais, et al.. (2009). Use of coated capillaries for the electrophoretic separation of stereoisomers of a growth hormone secretagogue. Electrophoresis. 30(21). 3772–3779. 38 indexed citations
12.
Royuela, Mar, François Rivier, Gérald Hugon, et al.. (2009). Dystrophin and dystrophin-associated protein in muscles and nerves from monkey. European Journal of Histochemistry. 47(1). 29–29. 4 indexed citations
13.
Rivier, François, Gérald Hugon, Vincent Guerlavais, et al.. (2003). dystrophin and dystrophin-associated protein in muscles and nerves from monkey. HAL (Le Centre pour la Communication Scientifique Directe). 1 indexed citations
14.
Royuela, Mar, Gérald Hugon, Ricardo Paniagua, et al.. (2003). Formation of multiple complexes between beta-dystroglycan and dystrophin family products. Journal of Muscle Research and Cell Motility. 24(7). 387–397. 17 indexed citations
15.
Guerlavais, Vincent, Damien Boeglin, Delphine Mousseaux, et al.. (2003). New Active Series of Growth Hormone Secretagogues. Journal of Medicinal Chemistry. 46(7). 1191–1203. 64 indexed citations
16.
Broglio, Fabio, Andrea Benso, Cristina Gottero, et al.. (2002). EP1572: A novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man. Journal of Endocrinological Investigation. 25(8). RC26–RC28. 42 indexed citations
17.
Guerlavais, Vincent, Patrick J. Carroll, & Madeleine M. Joullié. (2002). Progress towards the total synthesis of callipeltin A. Asymmetric synthesis of (2R,3R,4S)-3-hydroxy-2,4,6-trimethylheptanoic acid. Tetrahedron Asymmetry. 13(7). 675–680. 31 indexed citations
18.
Guerlavais, Vincent, et al.. (2001). New growth hormone secretagogues. Letters in Peptide Science. 8(3-5). 187–193. 2 indexed citations
19.
Guerlavais, Vincent, Damien Boeglin, Jean-Alain Fehrentz, et al.. (2001). New growth hormone secretagogues. International Journal of Peptide Research and Therapeutics. 8(3-5). 187–193. 3 indexed citations
20.
Paris, Marielle, et al.. (1998). Synthesis of peptide aldehydes on solid support using ozonolysis. Tetrahedron Letters. 39(40). 7287–7290. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel J. Burdick Breakdown of academic impact, for papers by Dennis G. Fry Breakdown of academic impact, for papers by Joseph L. Meuth Breakdown of academic impact, for papers by Jenny Chik Breakdown of academic impact, for papers by Naoki Teno Breakdown of academic impact, for papers by Shihong Ma Breakdown of academic impact, for papers by Wenjing Shang Breakdown of academic impact, for papers by Johnathan C. Maher Breakdown of academic impact, for papers by Agata Steenackers Breakdown of academic impact, for papers by Susan M. Medghalchi
Rankless by CCL
2026